Package 60505-4658-9

{"route": ["ORAL"], "spl_id": "34bede3a-5e85-4291-a95a-3e4d752e89f9", "openfda": {"upc": ["0360505465835", "0360505466139"], "unii": ["BEA68ZVB2K"], "rxcui": ["1482507", "1482515", "1482521", "1482525"], "spl_set_id": ["22f29752-614f-caaf-b595-9deae8a3e3ff"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (60505-4658-3)", "package_ndc": "60505-4658-3", "marketing_start_date": "20250506"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (60505-4658-9)", "package_ndc": "60505-4658-9", "marketing_start_date": "20250506"}], "brand_name": "Eslicarbazepine Acetate", "product_id": "60505-4658_34bede3a-5e85-4291-a95a-3e4d752e89f9", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "60505-4658", "generic_name": "Eslicarbazepine Acetate", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eslicarbazepine Acetate", "active_ingredients": [{"name": "ESLICARBAZEPINE ACETATE", "strength": "200 mg/1"}], "application_number": "ANDA211236", "marketing_category": "ANDA", "marketing_start_date": "20250506", "listing_expiration_date": "20261231"}